VitalHound

Orforglipron: the nonproprietary name for Foundayo

Orforglipron is the molecule sold as Foundayo, FDA-approved 1 April 2026. Oral. No food or water timing restrictions. A Bridge drug.

Updated August 19, 2026 · Educational — not a coverage decision

Meaning

Orforglipron is the generic (nonproprietary) name. Foundayo is the brand. On PAs and pharmacy lines, use the brand the demonstration lists: Foundayo.

What it is not

Not semaglutide. Not tirzepatide. Not a Wegovy pill with a different label.

Doors, in one line

Bridge $50 if approved. Commercial-plus-card ~$25 when legal. LillyDirect cash often ~$149 at the lowest dose. Not Extra Help. Not TrOOP if billed as Bridge.

Common error

Asking for 'orforglipron' and receiving a shrug, because the pharmacy computer is filed under Foundayo.

Questions

When was it approved?
1 April 2026.
Food rules?
No food or water timing restrictions as used on this site as of 19 August 2026. Follow the current label.
Is a generic on the shelf?
The nonproprietary name is not the same thing as an available generic substitute. Do not expect substitution.

Not sure this applies to you?

Answer a few questions and see your own numbers.

Free to see which path is likely cheapest for your coverage.

Check my options

See what your cheapest option is

Answering the questions is free. If the doctor-ready checklist helps, it's $39 once.